Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a randomised controlled trial - Concepedia

Concepedia

Publication | Open Access

Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a randomised controlled trial

DOI Full Paper Access

89

Citations

25

References

2015

Year

Peter Frith, Philip J. Thompson, Rajeev Ratnavadivel, Catherina L. Chang, Peter Bremner, Peter Day, Christina Frenzel, Nicol Kurstjens

Abstract

NCT01513460.

References

	Year	Citations

Page 1